Has Charity Huang received payments from drug or device companies?

Yes. Drug and device makers reported $15,526 in general payments to Charity Huang across 187 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charity Huang did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charity Huang come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charity Huang

Hematology & Oncology · Torrance, CANPI 1891157657

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 53 manufacturers reported payments, led by GSK at 47.5% of the total. 2025 is the largest year on record at $8,788, more than ten times the $710 reported in 2019.

$15,526in general payments, 2019–2025

Across 187 payments — averaging $83.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$7K
AstraZeneca$810
Johnson & Johnson$780
Sanofi$615
Novartis$445
Gilead$433
plus $5K from 47 others

$587,770in research payments, 2019–2025

Across 57 payments — averaging $10,312 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$370K
Seagen Inc.$102K
Eli Lilly$69K
Amgen$27K
Genentech, Inc.$16K
Regeneron$4K

What the payments were for

Consulting fees$7,40048%
Food & beverage$7,32147%
Education$8045%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	4	$7,372
AstraZeneca(2 entities)	17	$810
Johnson & Johnson	18	$780
Sanofi	7	$615
Novartis	8	$445
Gilead(2 entities)	13	$433
Lilly USA, LLC	6	$380
Seagen Inc.	7	$364
Janssen Scientific Affairs, LLC	6	$360
E.r. Squibb & Sons, L.L.C.	9	$356
Jazz Pharmaceuticals Inc.	4	$247
Boehringer Ingelheim	2	$230
Incyte Corporation	5	$227
Regeneron Healthcare Solutions, Inc.	4	$224
AbbVie	5	$223
Astellas Pharma US Inc	3	$205
Bayer	3	$164
Genentech USA, Inc.	5	$149
Amgen	4	$146
Portola Pharmaceuticals, LLC	1	$125
Karyopharm Therapeutics Inc.	4	$117
Bristol Myers Squibb	4	$116
Takeda Pharmaceuticals U.S.A., Inc.	2	$110
Daiichi Sankyo Inc.	4	$102
Beone Medicines USA, Inc.	3	$98
EMD Serono, Inc.	2	$90
Pfizer	3	$80
Stemline Therapeutics Inc.	1	$80
Pharmaessentia USA Corporation	2	$65
AVEO Pharmaceuticals, Inc.	3	$61
ADC Therapeutics America, Inc.	2	$61
Regeneron	1	$59
Deciphera Pharmaceuticals Inc.	2	$54
Menarini Silicon Biosystems, Inc.	2	$53
Servier Pharmaceuticals LLC	2	$50
Agios Pharmaceuticals, Inc.	2	$44
Genentech, Inc.	1	$44
Immunogen, Inc.	1	$32
Merck	1	$32
Syndax Pharmaceuticals, Inc.	1	$32
X4 Pharmaceuticals, Inc.	1	$28
Coherus Oncology, Inc.	1	$27
Springworks Therapeutics, Inc.	1	$26
Pharmacosmos Therapeutics Inc.	1	$24
Mirati Therapeutics, Inc.	1	$24
AMAG Pharmaceuticals, Inc.	1	$23
Eisai Inc.	1	$23
Morphosys, US Inc.	1	$23
Blueprint Medicines Corporation	1	$23
Kyowa Kirin, Inc.	1	$21
Exelixis Inc.	1	$18
CTI Biopharma Corp.	1	$15
Pharmacyclics LLC, An Abbvie Company	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SHINGRIX$7,250
LIBTAYO$269
JARDIANCE$230
VYXEOS$150
TALVEY$150
SARCLISA$150
Elahere$128
MONJUVI$125
Trodelvy$125
DARZALEX$125
TECVAYLI$125
CARVYKTI$125
Enhertu$125
ANDEXXA$125
ENJAYMO$123
BLENREP$122
ELITEK$122
Stivarga$122
PROMACTA$116
TASIGNA$116

How this compares

$15,526 in reported general payments places this provider in the 70th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Other hematology & oncology in Torrance

Dennis SlamonLos Angeles$3.1M
Sandra HorningStanford$2.5M
Mohammadbagher ZiariCorona$2.5M
George YaghmourLos Angeles$1.9M
Robert VescioWest Hollywood$1.1M
Kevin KellyLos Angeles$894K
Johnny ChangEncino$884K
Nitin RohatgiSacramento$814K
Omid HamidSanta Monica$809K
Catherine CoombsOrange$786K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →